Medical Patch Maker Corium International, Inc. Updates Plans To Raise Up To $76 Million In IPO

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Corium International on Monday updated its plans to go public, saying it could raise up to $76 million. The Menlo Park company led by CEO Peter Staple plans to sell 5.5 million shares in an IPO priced between $10 and $12, with another 825,000 shares available to underwriters. Corium has publicly disclosed about $40 million in venture funding, including money from Essex Woodlands Health Ventures, which holds about a 56 percent stake in the company.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC